Arriving in the field of weight management therapy, retatrutide represents a unique approach. Unlike many existing medications, retatrutide works as a twin agonist, simultaneously targeting both glucagon-like peptide-1 (GLP-1) and glucose-responsive insulinotropic polypeptide (GIP) receptors. The dual activation promotes multiple beneficial effects… Read More